Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Brandywine Realty Trust ( BDN - Snapshot Report ) recently completed the sale of a two-building office property -- Pacific Ridge Corporate Center, located in Carlsbad, California -- for $29 million. The net proceeds from the transaction will be used by Brandywine for general corporate purposes. At the time of closing of the transaction, the 121,381 square foot property was 84% leased.
Through this strategic initiative, Brandywine expects to enhance the quality of its portfolio and use the additional capital, which it generates for other investment activities. The asset divestiture strengthens the company’s financial flexibility by providing it with additional liquidity. The portfolio repositioning strategy on the company’s part is to sell the non-core properties and recycle capital into lucrative markets.
With this deal, Brandywine completed its $123 million worth property sales in 2012, and remains well placed to achieve its target of asset sale worth $175 million in 2012 as per its business strategy.
During the first quarter of 2012, the company completed the disposition of a fully leased; 268,240 square foot office building located in Herndon, Virginia for $91.1 million and also completed the disposition of a 32,978 square foot office building in Moorestown, New Jersey for $3.0 million.
Brandywine Realty is one of the largest publicly traded integrated real estate companies in the United States. The company owns, develops, manages and has ownership interests in a primarily Class A, suburban and urban office portfolio comprising 306 properties totalling 34.6 million square feet.
Brandywine Realty currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We also have a long-term Neutral recommendation on the stock. One of its competitors, Mack-Cali Realty Corp. ( CLI - Analyst Report ) holds a Zacks #4 Rank, which translates into a short-term Sell rating
Read the full reports :
Snapshot Report on BDN
Analyst Report on CLI